AUTHOR GUIDELINE
Journal of Medical Pharmaceutical and Allied Sciences (JMPAS) is a bi-monthly published journal that publishes original research articles, review articles, case reports, and short communications. The journal focuses on publication with facilities for online research article downloading & email alerts. Only those manuscripts are accepted for review and publication whose work has not been published and is not under consideration for publication elsewhere, also its submission for publication has been approved by all authors and institutions where the actual work was carried out.
(SEE TEMPLATE FOR MANUSCRIPT PREPARATION AT LAST)
Types of manuscripts
1. SUBMISSION
As part of the submission process, authors must ensure their submission complies with the following guidelines. Failure to adhere to these guidelines may result in the return of the submission:
Authors are required to submit a graphical abstract (feature figure) upon manuscript acceptance. This concise, visually appealing summary captures the paper's essence, aiming to engage a broad readership and aid database compilation. The graphical abstract, accompanied by a brief text (up to 30 words), must be carefully drawn, colored, and fit within 12 cm (width) x 6 cm (height). It should have a minimum resolution of 600 dpi (1200 dpi for line art), with the image's height not exceeding half of its width. Accepted formats include JPG, PDF, Word, PowerPoint, or PNG.
Any sort of submission implies that the content and idea have not been published or submitted elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
For submission of the manuscript; log in at https://jmpas.com/menuscript follow the submission steps as required and submit the manuscript
If you are invited to revise your manuscript after peer review, the journal shall also request the revised manuscript to be formatted according to journal standard requirements as mentioned below.
2. AIMS AND SCOPE
The journal of Medical Pharmaceutical and allied sciences (www.jmpas.com) is a single-blind, peer-reviewed open access scientific journal. We are fulfilling all guidelines of Scopus, Index Copernicus, and UGC and indexed with the same. This will help our authors to prove the high impact factor for their manuscript. Journal offers authors fast review and decision times, a continuous-publication format, and global distribution for their research work. All manuscripts are precisely copy-edited and typeseted to ensure quality.
The journal operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. All articles published are made freely and permanently accessible online immediately upon publication, without subscription charges or registration process. Further information about open access can be found at www.jmpas.com.
JMPAS is a journal that aims to publish well-written, high-quality articles focusing on important questions in basic research within the fields of Medical and Pharmaceutical Sciences. The journal covers a wide range of topics in these disciplines, including various subspecialties such as medical sciences, Pharmacology, Toxicology, Clinical trials, pre-clinical study, Pharmacovigilance, Pharmaceutical Chemistry, Clinical Research, and all of the allied subjects. It welcomes articles in different categories, including perspectives, research articles, systematic reviews, meta-analyses, review articles, short communications, case reports, research letters, letters to the editor, images, and book reviews, and preferably newer research concepts. JMPAS does not publish work on the actions of biological extracts of unknown chemical composition (e.g. unpurified and invalidated) or unknown concentration. Articles that involve investigations on tobacco, smoking, alcohol, cocaine, and other substances of abuse whether directly or in the context of their use to generate a disease model (e.g. smoking for pulmonary disease) will be considered on scientific merit (which includes ethical justification) and relevance to medical and pharmaceutical aspects.
Manuscripts should present new and significant findings in medical and pharmaceutical science and should not have been published or under consideration elsewhere. Following an initial review by the editorial board, all articles will undergo evaluation by external reviewers. The selection process for publication entails evaluating the research articles based on their novelty of research, and research merits, which encompass various factors like maintaining high-quality standards, showcasing originality, and demonstrating relevance to the readership. Authors are encouraged to submit their articles to the journal, specifically if their work falls within the specialties of medical sciences, Pharmacology, Toxicology, Clinical trials, pre-clinical study, Pharmacovigilance, Pharmaceutical Chemistry, Clinical Research, Chemistry, Zoology, Botany, Biochemistry, Biomedical Sciences, Bioinformatics, Chemoinformatics, Microbiology, and Immunology.
As authors of articles published in the JMPAS (www.jmpas.com), you are the copyright holders of your article and have granted to any third party, in advance, and in perpetuity, the right to use, reproduce or disseminate your article, according to the JMPAS copyright and license agreement.
For those authors who are government employees or are prevented from being copyright holders for similar reasons, the JMPAS can accommodate non-standard copyright lines. Please contact [email protected] regarding any query
3. Article Preparation Support
JMPAS manuscript writing Services offer expert help with English language editing as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design, so you can submit your manuscript with better illustration in terms of graphs, images, and flowcharts.
3.1. Submission of a manuscript to JMPAS
Manuscripts are accepted based on the understanding that the authors shall have obtained the necessary authority for publication. Manuscripts with multi-authors imply the consent of each of the authors. The publisher shall presume that the corresponding author has specifically obtained the approval of all other co-authors to submit the article to JMPAS. Submission of an article to JMPAS shall imply that it has not been either published or not being considered for publication elsewhere.
Manuscripts shall have the format of a font size of 12 points, 1.5 lines-spacing (includes Tables, Flowcharts, etc.). Each page shall have a uniform size with at least 1.5 cm margins on all sides. Upon acceptance, authors shall be asked to fill out the copyright transfer form, and cover letter which is available on https://jmpas.com/copyright-form. The manuscript can also be submitted through the Online Manuscript Submission system: https://jmpas.com/menuscript
4. MANUSCRIPT CATEGORIES AND REQUIREMENTS
It is advisable to minimize the use of abbreviations in the manuscript and it shall be defined during its first use; moreover, non-approved abbreviations shall be avoided
i. Research Articles/Case Study
Description: The scope shall have logic and, a research paper shall not exceed 15 printed pages. Novel research or mechanisms shall be prioritized; like validation of new analytical approaches, methods, or models which shall constitute a significant contribution to enhancing scientific knowledge. Papers that reassess scientific and medical concepts based on earlier results along with purely theoretical papers shall be considered. Papers describing new methods in research that embody new principles shall also be in the scope. We urge and encourage the publication of replication studies that contain major importance to medical, pharmaceutical, and allied sciences. However, it shall be subject to the discretion of the senior editorial board members
a. Manuscript: Word limit; 4,000 words, excluding abstract, methods, references, and figure legends
b. Abstract: 250 words; shall be a narrative abstract consisting of a short version of the whole paper. There are no headings within the narrative abstract. The author simply tries to summarize the paper into a story that flows logically. No abbreviation should be used
c. Methods: shall be fully transparent with sufficient detail to enable replication by others
d. Discussion: 500 words
e. Conclusions: 1,50 words
f. References: Reference shall be between 05-60 numbers, with a focus on primary publications
g. Title: 160 characters (including spaces)
h. Keywords: Supply between 3 and 7
i. Figures/Tables/Graphs: Total of number, not more than 10 figures (image format only), and tables (text or editable format) excluding supporting files
ii. Technical notes/Short Communication
It shall contain new, important information that has not been published yet, and for which publication is desirable. This section shall not exceed 5 printed pages. An explanatory statement shall be required for prioritized publication. In a nutshell, Technical notes/Short Communication should be between 1-5 pages. Abstract: Up to 150 words, unstructured. References: Up to 30. Figures: No more than three (one of which shall summarize the major findings discussed). Tables: No more than two.
iii. Review articles
The review article shall not exceed 15 printed pages. It should be concise; moreover, it should have critical surveys of novel accomplishments in the research field and should bring up the most important current topics or present interpretative and critical accounts. However, it should not be a simple compilation, of subjects of general interest. Description: Reviewers are comprehensive analyses of scientific literature following the standard submission procedure. Word limit: 2,000-4,000 words excluding abstracts, references, and figure legends. Title: Up to 160 characters (including spaces). Abstract: Up to 150 words; must be non-structured. References: Up to 60 references. Structure: Authors should break up their reviews into headed sections. Figures/Tables: There should be a minimum of two figures one of which should illustrate the major findings/pathways discussed. There should be a total of no more than 5 figures and tables (combined). It is advisable to use explanatory figures in the form of cartoons, flow diagrams, etc.
5. REFERENCES FORMAT
The authors are responsible for the accuracy of the bibliographic information. It shall be numbered consecutively corresponding to the order of their citation along with designated by superscript with square brackets after the punctuation marks. e.g.[10]. A list shall be included on separate 1.5-spaced pages at the end of each text. Other information shall be removed from references such as any website link, month name, or any other unproductive part. All references shall have a basic structure as below.
The style and punctuation of the references shall conform to the following examples:
Journal (Use “et al” for more than 3 or Three Authors)
1. Cantarelli MA, Pellerano RG, Marchevsky EJ, et al, 2011. Title of the article. (Full name of journal) Analytical Science 27 (6), Pages- 173-178. DOI number.
2. Sather BC, Forbes JJ, Starck DJ, et al, 2007. Title of the article. (Full name of Association). 47(4), Pages 82-85.DOI number
Books
1. Meltzer PS, Kallioniemi A, Trent JM,2002.Chromosome alterations in human solid tumors. In: Vogelstein B and Kinzler KW (edition.). The Genetic Basis of Human Cancer, New York; McGraw-Hill, pp. 93-113.
2. Bard AJ, Faulkner LR, 2001. Electrochemical Methods: Fundamentals and Applications.
2nd ed., New York, John Wiley, and Sons. pp. 221-223
Patents
1. Aviv H, Friedman D, Bar-Ilan A, Vered M. US Patent, US 5496811, 1996.
Organization
1. WHO or Full name of Organization with the name of the person responsible if have, 2019. General's opening remarks at the media briefing on COVID-19. Document number or edition or revision number or issue number.
6. SUMMARY OF MANUSCRIPTS PREPARATIONS
File Formats: Submit Word files with tables electronically embedded within the text(Times New Roman:12) of the document having at least 1.5 cm margins on all sides. Photos and graphs shall be clear and easy to read and interpret. All pages, images, graphs, and tables shall be in portrait orientation style in jpg format.
Manuscript Title: Top of paper, Times New Roman; Fonts all caps, bold, 12 points.
Author Names: The first name, followed by full last name, and corresponding author of the manuscript must be marked with an asterisk* and shall be listed first, font: bold, 12 points. (JMPAS does not allow more than 5 author names in a single article, for additional names, you need to submit an extra processing fee per author)
Authorship Policy:
The list of authors shall accurately illustrate who contributed to the work and how. All those listed as authors shall qualify for authorship according to the following criteria:
Institution Name: Institution addresses and postal address in 12 points
E-mail: Email of the corresponding author, 12 points
Orchid ID:
First-page file: It shall contain the Manuscript title, Author detail, Affiliation, Email, and Address for correspondence
Article file: It shall contain as per the below sequences (MS Word file only)
Manuscript Title, Abstract, Keywords, Introduction, Materials, and Methods, Result, and Discussion, Conclusion. Acknowledgement, Conflict of Interest, References. (All tables, images, and graphs shall be adjusted)
The following formatting style is required for manuscript submission:
ABSTRACT: The abstract shall be structured; this shall indicate why the study was performed and what question was intended to answer. Times New Roman, 12 points font size, with 1.5 line spacing All Research, Research Notes, Reviews, Tools, Experience, and Commentary articles shall include structured abstracts of 200 to 250 words. No abbreviations should be used
Text: Times New Roman, 12 points font size, texts of the document with 1.5 line spacing Use subheads to introduce the article's main sections.
INTRODUCTION
In the introduction state the background of your work and its purpose. State your hypothesis and the questions asked. Provide only essential background. A thousand words are generally more than sufficient. Provide a context or background for the study. Explain the objective of the research or review or the hypothesis used. Provide literature with references related to your research or review. Provide only directly pertinent references, and do not include data or conclusions from the work being reported.
MATERIAL AND METHODS
To facilitate transparency, ‘Methods’ are not included in the word count of Research Papers. Your methods shall be described with sufficient details to allow the experiments to be interpreted and repeated by an experienced investigator. Wherever published methodologies are used, references shall be given along with a brief outline: any references shall provide the full description and shall not be a signpost to another reference. If this is an issue, please provide the full description of the method in your manuscript.
For experimental studies, the methods shall be presented in sections and shall cover
• Test systems used (animal preparations, isolated tissues, cultured cells, in vitro systems, etc.) and the measurements made (with technical details) for each system
• Where animals have been used as a test system the Journal has strict requirements for the reporting of experiments involving animals or animal tissue (shall be approved by the animal ethical committee of the certain country)
This shall state in outline what experimental methods were used. Details on media, buffers, drug concentrations, time points, statistics, etc., shall not be given unless they are important to the question that was addressed. The Method section shall include only information that was available at the time of the plan or protocol for whatever the study was being written; all information obtained during the study shall be included in the results section. The author shall provide the appropriate reference for every method used in research work.
For all studies, experimental design, data analysis, and statistical procedures shall be consistent with the principles explained in the editorial Experimental design and analysis and their reporting.
Scientific justification shall be provided for the animal species and each model selected for the study. For instance, “this model of pain in rats replicates aspects of the human pain pathway”.
Make a statement of ethical approval for experimentation that will be recognized worldwide. Indicate the nature of the ethical review permissions, and national or institutional guidelines for the care and use of animals, that cover the research. Include application approval numbers and web addresses of the approving organizations, if available.
For further details, please see the journal's Ethics Policy.
RESULT & DISCUSSION
As well as summarizing the main implications that follow from the results, and mentioning important shortcomings and caveats, this paragraph shall clearly state in what ways the work has advanced understanding in the field.
Results
Present your results in logical sequence in the text, tables, and illustrations along with giving the main or most important findings first. Do not repeat all the data in the tables or illustrations in the text; emphasize or summarize only the most important observations. When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables.
Discussion
Emphasize the novel and important aspects of the study and the conclusions that follow from them in the context of the totality of the best available evidence. Do not repeat any detailed data or other information given in the Introduction or the Results section. For experimental studies, it is useful to begin the discussion by briefly summarizing the main findings, then explore possible mechanisms or explanations for these findings, compare and contrast the results with other relevant studies, state the limitations of the study, and explore the implications of the findings for future research and clinical practice
CONCLUSION
Link the conclusions with the goals of the study but avoid unqualified statements and conclusions not adequately supported by the data. Avoid claiming priority or alluding to work that has not been completed. States new hypotheses when warranted but labels them clearly as such.
Tables, Graphs, and figures
Must be appropriately inserted within the text. All images, graphs, and tables shall be in portrait orientation style. The author can also upload figures (image format only like jpg, jpeg) and tables as supplementary files separately also
Tables
These should be numbered with Arabic numerals. Each table should be typed using a table format (i.e., each variable must be typed into a separate cell in the table) with only horizontal lines above and below the table column headers and at the bottom of the table. No vertical lines should be included in any table. The title should be typed at the top of the table in the sentence case format, i.e., only the first name should be in capital letters; as appropriate. Any footnote should be typed at the bottom of the table in italics.
Figures
Figures must be numbered independently of tables, multimedia, and 3D models and cited as the relevant point in the manuscript text, e.g. "Figure 1", "Figure 2", etc. All figures including photographs should be numbered consecutively in Arabic numerals in the order of their appearance in the text and bear a brief title in lowercase boldface letters below the figure. Do not duplicate data by presenting it both in the text and in a figure. For any figure directly extracted from previously published materials, you must have written permission from the publisher of that figure for reprint use. A copy of that permission release must be submitted with your article.
Acknowledgment
Contributors who do not meet the criteria for authorship shall be listed under acknowledgements along with a description of their specific contributions. Individuals provide technical or writing assistance and a department chair provides general support.
Conflicts of Interest
Authors shall disclose any personal or financial relationships that can be viewed as potential conflicts of interest about the publication on the manuscript file just before the references section.
Formatting of funding sources
List funding sources in this standard way to facilitate compliance with the funder's requirements
Chemical Terminology: The chemical nomenclature used must be that used in the Chemical Abstracts
Biological Nomenclature: Names of plants, animals, and bacteria should be in italics.
Enzyme Nomenclature: The trivial names recommended by the IUPAC-IUB Commission should be used. When the enzyme is the main subject of a paper, its code number and systematic name should be stated in its first citation in the paper.
Symbols and Abbreviations:
Journal names should be abbreviated according to
Index Medical journal abbreviations:
http://www.nlm.nih.gov/tsd/serials/lji.html
List of title word abbreviations:
http://www.issn.org/2-22661-LTWA-online.php
CAS (Chemical Abstracts Service):
http://www.cas.org/content/references/corejournals.
Ethical Matters
Authors involved in the usage of experimental animals and human subjects in their research work should seek approval from the appropriate Institutional Animal Ethics Committee by "Principles of Laboratory Animal Care". The material and methods section of the manuscript should include a statement to prove that the investigation was approved and that informed consent was obtained.
Authorship
A manuscript will be considered for publication based on the below understanding:
Galley Proof
Unless indicated otherwise, galley proofs are sent to the address given for correspondence. It is the responsibility of the corresponding author to ensure that the galley proofs are returned without delay
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party
Author Fees
You would not be charged any publication or Article Submission fees for JMPAS. If this paper is accepted for publication, you will be asked to pay online maintenance fees and fees for the E-Certificate. The corresponding author will have to pay the following amount as editorial team support, evaluation, and editor's peer reviewing fees for which a mail regarding the mode of payment will be communicated to the authors by the editorial manager of the Journal (SEE PUBLICATION CHARGES IN ABOUT US
https://jmpas.com/publication-charges )
Cancellation and Refund Policy
You, as a researcher/Author, understand that upon initiating a Transaction You are entering into a legally binding and enforceable contract with the Journal of Medical Pharmaceutical and Allied Sciences to avail yourself of the services from the journal using the Payment Facility, and you shall pay the Transaction Price through Your Issuing Bank to the journal using Payment Facility.
You, as a researcher/Author, may agree with the Journal of Medical Pharmaceutical and Allied Sciences through electronic communication and electronic records and using the automated features as may be provided by the Payment Facility on any extension/increase in the publication time, and the Transaction shall stand amended to such extent. Any such extension/increase of publication time or subsequent novation/variation of the Transaction should comply with Payment Facility Rules and Policies.
You, as a researcher/Author, shall be entitled to claim a refund of the Transaction Price (as Your sole and exclusive remedy) in case You do not receive the service within the period agreed in the Transaction or within the period as provided in the Policies, whichever is earlier. In case you do not raise a refund claim using Website features within the stipulated time then this would make you ineligible for a refund. After the publication of your article, you will be ineligible for a refund and no refunds can be claimed.
You, as a researcher/Author, understand that the Payment Facility may not be available in full or in part for certain categories of services and/or Transactions as mentioned in the Policies and hence you may not be entitled to a refund in respect of the Transactions for those services.
Wrongly deposit money or extra deposit money will be returned within 03 weeks if the respective candidate informs us within 02 days after the date of the money deposit or transaction.
INR 1000 + Transaction Charges or USD 40 + Transaction Charges will be deducted If the Author wishes to cancel the publication with us after completing Payment but has yet to complete the Final Submission.
The refunds will be made by net banking or electronic payment transfers only. Refunds may be supported by select banks. Where a bank is not supported for processing refunds, you must share alternate bank account details with us for processing the refund. A refund shall be made in Indian Rupees only and shall be equivalent to the Transaction Price received in Indian Rupees.
Once the paper/article is published with the respective Volume/ Issue, the Article's online maintenance fees and fees of the E-Certificate will not be returned or reversed back to the author.
Commercial advertisement is not allowed in our journal.
TEMPLATE FOR RESEARCH ARTICLE
(Font style- Times New Roman; Font Size- 12; Line Spacing-1.5)
TITLE (Should be All Caps and Bold)
Author1, Author2* (Full name in Bold with affiliations nos. and marked * for corresponding)
1Affiliation
2*Affiliation
Corresponding Author Details*
Author2*
Affiliation
Phone Nos.
Mail id:
ORCID ID
ABSTRACT: (Up to 250 words without reference)
KEYWORDS: 3-7(which are more relevant to the manuscript)
INTRODUCTION: Cite references as [1], [2,3], [4-7] just before the full stop.
MATERIALS AND METHODS: (Should be novel and unique)
RESULTS AND DISCUSSION: (Insert figures and table and write as Figure 1 and Table 1).
CONCLUSION: Up to 150 words
ACKNOWLEDGEMENT: (if any)
REFERENCES: (In Numbering)
*Note: The Journal of Medical Pharmaceutical and Allied Sciences is not responsible for the updation of articles in the indexing organization. We are the only publisher of the article and work as a third party.
We suggest authors please check the indexing details directly on the indexing organization's website.